We argue that the long-term focus on HTA's technical inputs and related processes has failed because it implicitly endorses the state's framework. It misses the importance of making a philosophical case against a system whose primary flaw is that patients are servile to the state's economic interests.
Make the case against the state's imposition of economic interests as the only consideration
January 21, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
The symptoms have been identified, but the widely held belief about the cause is a miss
September 30, 2025 - - Latest News -
UK companies are granted more time to decide on pricing agreement
September 29, 2025 - - Latest News -
Anatara strengthens board with the appointment of Dirk van Dissel
September 29, 2025 - - Australian Biotech -
CLINUVEL advances next-generation peptide drug formulations
September 29, 2025 - -
Alterity Therapeutics targets major market with ATH434 in Multiple System Atrophy
September 29, 2025 - - Australian Biotech -
Lower than expected uptake of new therapies impacts PBS spend
September 29, 2025 - - Latest News -
Chimeric reports encouraging early data from CHM CDH17 trial
September 29, 2025 - - Australian Biotech